Authorized purpose: LungVision segments prior 3D CT and registers and overlays it with live fluoroscopic X-ray of the same anatomy to support catheter and device navigation during pulmonary procedures.
Clinical role
Image registration and overlay support for catheter or device navigation during pulmonary procedures.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Pulmonary anatomy and catheter/device navigation targets
Key limitation
Keep in mind: The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: LungVision segments prior 3D CT and registers and overlays it with live fluoroscopic X-ray of the same anatomy to support catheter and device navigation during pulmonary procedures.
Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Pulmonary anatomy and catheter/device navigation targets Input: Previously acquired 3D CT of the relevant anatomy and live fluoroscopic X-ray of the same anatomy.
Who uses it?Intended users: Trained interventional pulmonologists, radiologists, surgeons, and procedure-room staff.
What does the software produce?Output: A segmented CT registration and overlay displayed with live fluoroscopy to support pulmonary catheter or device navigation.
What is its most important limitation?Key limitation: The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
Clinical takeaway. Clinical role: LungVision segments prior 3D CT and registers and overlays it with live fluoroscopic X-ray of the same anatomy to support catheter and device navigation during pulmonary procedures.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports nonclinical bench testing in which the device met all requirements specifications, including verification testing of the requirements, testing of hazards mitigations, and performance testing of the system, plus testing with pig lungs to test accuracy in deformable tissue and testing to ANSI AAMI ES 60601-1 and IEC 60601-1-2. It states no animal testing and no clinical testing was performed. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
LungVision segments prior 3D CT and registers and overlays it with live fluoroscopic X-ray of the same anatomy to support catheter and device navigation during pulmonary procedures.
The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
The exact FDA document reports nonclinical bench testing in which the device met all requirements specifications, including verification testing of the requirements, testing of hazards mitigations, and performance testing of the system, plus testing with pig lungs to test accuracy in deformable tissue and testing to ANSI AAMI ES 60601-1 and IEC 60601-1-2. It states no animal testing and no clinical testing was performed. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "We have performed bench tests and found that the BodyVision met all requirements specifications and was found to be equivalent in comparison to the predicate." … "Testing includes verification testing of the requirements, testing of hazards mitigations, and performance testing of the system.". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports nonclinical bench testing in which the device met all requirements specifications, including verification testing of the requirements, testing of hazards mitigations, and performance testing of the system, plus testing with pig lungs to test accuracy in deformable tissue and testing to ANSI AAMI ES 60601-1 and IEC 60601-1-2. It states no animal testing and no clinical testing was performed. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "We have performed bench tests and found that the BodyVision met all requirements specifications and was found to be equivalent in comparison to the predicate." … "Testing includes verification testing of the requirements, testing of hazards mitigations, and performance testing of the system.". Read from the exact FDA decision document on 2026-11-14.
No single product-level sensitivity value was promoted because the reviewed FDA material is workflow, module, sequence, or population specific.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No single product-level specificity value was promoted because the reviewed FDA material is workflow, module, sequence, or population specific.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K163622 FDA evidence package for Lung Vision
DesignFDA 510(k) verification and validation evidence described in the exact submission
PopulationPulmonary anatomy and catheter/device navigation targets
Scopeexact submission
Tested versionLungVision System
IndependenceSponsor or vendor study
K163622
Manufacturer evidence submitted for the exact FDA decision. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Previously acquired 3D CT of the relevant anatomy and live fluoroscopic X-ray of the same anatomy.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The FDA package describes PC or laptop components, video capture, customer-supplied imaging and display connections, and live-fluoroscopy overlay; exact room interfaces and failure handling require testing.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The FDA package describes a procedure-room system using PC or laptop components connected to customer-supplied imaging and display devices; current hardware, network, and service boundaries require site confirmation.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: A segmented CT registration and overlay displayed with live fluoroscopy to support pulmonary catheter or device navigation.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: A segmented CT registration and overlay displayed with live fluoroscopy to support pulmonary catheter or device navigation.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA package describes a procedure-room system using PC or laptop components connected to customer-supplied imaging and display devices; current hardware, network, and service boundaries require site confirmation.
The FDA package describes PC or laptop components, video capture, customer-supplied imaging and display connections, and live-fluoroscopy overlay; exact room interfaces and failure handling require testing.
Only trained interventional pulmonologists, radiologists, surgeons, and procedure-room staff. should operate or interpret this product. Local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor K163622 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
The FDA package describes a procedure-room system using PC or laptop components connected to customer-supplied imaging and display devices; current hardware, network, and service boundaries require site confirmation.
exact submission · checked 2026-09-04
FDA-described deployment details do not establish current hosting contracts, security controls, uptime, or local qualification.
The FDA package describes PC or laptop components, video capture, customer-supplied imaging and display connections, and live-fluoroscopy overlay; exact room interfaces and failure handling require testing.
exact submission · checked 2026-09-04
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04
No exact-product price or product-specific reimbursement was established in the reviewed public material.
Monitor K163622 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The system depends on previously acquired CT, live fluoroscopy, registration quality, and customer-supplied imaging and display devices. It supports navigation and does not replace procedural judgment or direct visualization.
exact submission · checked 2026-09-04
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-04Last searched
25Fields reviewed
11Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
Screened one trial record. It names the LungVision platform but does not establish the K163622 cleared configuration or tested version, so it remains quarantined as product-family evidence. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared product version was established. Obtain a written quote separating license, implementation, interfaces, compute, storage, training, support, upgrades, renewal, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-04 - Exact FDA submission
The FDA decision material does not establish the complete security posture for the exact product and deployment. Obtain architecture, identity, audit, encryption, retention, support-access, vulnerability-management, and incident-response evidence.
Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: Cercare Neurosuite with Capillary Function and Oncology Virtual Expert processes CT or MR information to provide perfusion, tissue-blood-volume, diffusion, labeling, and quantification support for adult brain glioma workflows.
Modality
Radiological images; modality varies or is not specified in FDA list
Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.
Modality
Radiological images; modality varies or is not specified in FDA list
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.